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Background: There is an increasing awareness of the role of the cerebellum not only in motor, but also in
cognitive and emotional functions. Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant hereditary
ataxia characterized by a relatively pure cerebellar phenotype. Cognitive impairment has been reported in studies
with phenotype descriptions of SCA14, but previous studies have been small without control groups, and no
homogeneous and systematic test panel has been used. The objective of this study was to thoroughly characterize
the neuropsychological profile in ten Norwegian SCA14 subjects compared to unaffected family members and
population norm data.
Methods: Ten SCA14 subjects and ten intrafamilial unaffected age- and education-matched controls from two
Norwegian families were included. The unaffected intrafamilial controls included six first degree relatives, two
second degree relatives, and two spouses. General intellectual ability, memory, visuoperceptive skills, psychomotor
speed, executive functions, depression and anxiety were examined using internationally standardized tests, with
minimal need for manual response to avoid motor bias.
Results: No significant cognitive deficit was found in SCA14 subjects compared to intrafamilial controls. Verbal IQ,
verbal executive function and psychomotor speed tended to be reduced in affected subjects, but previously
reported non-verbal executive dysfunction was not confirmed in this study.
Conclusion: Only subtle cognitive impairment was found in SCA14 affected subjects. The current findings do not
confirm earlier reports of cognitive dysfunction in SCA14, but does shows a mild impairment in specific verbal
executive functions. Genotypic differences may partly account for this discrepancy, and further studies on larger
materials are needed to verify the findings.
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Cerebellum is traditionally viewed as being mainly an
important part of the motor system in the coordination
of movement and motor learning. During the last two
decades there has been a growing interest for the cere-
bellum’s role also in non-motor functions, with the
introduction of the “dysmetria of thought”-hypothesis and
the clinically described Cerebellar Cognitive Affective
Syndrome (CCAS) [1], consisting of executive dysfunc-
tion, visuospatial and verbal impairment and affective
dysregulation. In addition, neuroanatomical [2], evolu-
tionary [3-5] and functional imaging [6,7] findings sup-
port a role of the cerebellum in cognition.
Autosomal dominant cerebellar ataxias (ADCAs) are
neurodegenerative inherited disorders with progressive
ataxia. Additional signs and symptoms may be present,
such as polyneuropathy, pyramidal signs or cognitive
impairment. Genotypically, ADCAs may present with
conventional mutations or expansions. There appears to
be a marked difference in the way the two categories of
mutations affect the extracerebellar domains [8]. Con-
ventional mutation ADCAs tend to present with a pure
cerebellar phenotype with marked isolated cerebellar
atrophy. Most studies of cognition in ADCAs have been
done in polyglutamine expansion SCAs and show a wide
variety of cognitive deficits [9-15]. Fewer studies have
been done in ADCAs with conventional mutations, but
the cognitive profile in these ADCAs should be particu-
larly interesting, as impairment is expected to result from
a relatively pure cerebellar dysfunction.
Spinocerebellar ataxia type 14 (SCA14, OMIM; Mendelian
Inheritance in Man 605361) is characterized by a mild and
slow neurodegeneration with onset between 10–60 years,
and with cerebellar symptoms and clinical cerebellar signs.
The disorder is described as rare, representing 1.5-4% ofTable 1 Earlier reports of cognitive function in SCA14
Author IQ Number of patie
Klebe et al. [17] 1 tested - normal global IQ 15
2 patients extens
Stevanin et al. [27] 4 out of 7 indications of low IQ and
difficulty with abstract thinking*
18
2 patients extens
Hiramoto et al. [25] n.a. 5
Miura et al. [26] Total IQ (66,73,93), verbal IQ (79,77,90),
performance IQ (58,74,99)
3
*Evaluated by Progressive Matrix 47.the European ADCA families [16,17]. SCA14 shows a
relatively pure cerebellar phenotype [18-20], though minor
extracerebellar symptoms and signs may be present. The
disease is associated with point mutations in the PRKCG
gene which is expressed throughout the central nervous
system, most prominently in Purkinje cells. According to
the theory of cerebellar somatotopy [21], cognitive and
affective functions have been related to the posterior lobe
and vermis especially in the lateral regions of lobule VI
and VII (Crus I, Crus II, and VIIB) [6]. Radiologically, cere-
bellar atrophy is reported in SCA14 patients and is most
pronounced in the vermis and posterior lobe [19,22-24],
and one could thus expect vulnerability for non-motor
symptoms in SCA14 patients.
Cognitive impairment has been reported in studies with
phenotype descriptions of SCA14 (Table 1) [17,25-27], but
detailed cognitive evaluation is only reported in a few
cases, with no control groups [18]. Our primary objective
was to systematically investigate cognitive impairment in
SCA14 as compared to intrafamilial controls and norm
data. As a secondary aim we wanted to assess the impact
of motor symptoms severity and disease duration on
neuropsychological performances.
Methods
Participants
Subjects
Two SCA14 families were identified during an ongoing
project on hereditary ataxias in Norway [19,28]. Ten mu-
tation carriers, nine from family 1 and one from family 2
(Table 2), were initially included in the study as affected
subjects, independently of clinical signs and symptoms.
This group included seven males and three females, with
an age range between 17 and 54 years. They represented
all identified subjects with SCA14 above the age of 16 innts Other cognitive features
Patient 1: deficits in abstract thinking and shifting, verbal
fluency and inhibitory control, subcortical dementia.
ively tested Patient 2: memory deficit and impaired executive functions,
impaired working memory, increased sensibility to proactive
interference in memory, tendency to perseverate. 2 out of 15
characterized as demented on clinical impression only
Patient 1: executive function deficit, difficulties with memory
encoding and retrieval, attention deficit, cognitive slowing,
impaired working memory, concept shifting, abstract thinking,
resistance to interference and inhibitory control
ively tested
Patient 2: impaired executive functions, tendency to
perseverate, attention deficit, lack of inhibitory control
1 patient described with mental retardation, 4 patients
described with no intellectual disturbance
Visual memory deficit in 1
Table 2 Clinical characteristics of SCA14 subjects
Patient Age at examination,
y
Age at onset,
y
SARA
baseline
SARA 3 years
follow up
MMS MRI
Family 1
V-5 49 12 5.50 8.50 29 Cerebellar atrophy, most prominent in vermis
V-3 45 20 6.00 9.00 29 Cerebellar atrophy, most prominent in vermis
V-4 43 35 5.50 10.00 30 Cerebellar atrophy, most prominent in vermis
VI-3 20 10 10.50 12.50 29 Cerebellar atrophy
VI-1 20 10 4.00 5.00 30 **
VI-2 17 10 5.00 6.50 30 Minimal cerebellar atrophy
V-1 44 29 5.00 6.50 30 Cerebellar atrophy, most prominent in vermis
V-8 46 45 0.00 2.50 30 Cerebellar atrophy, most prominent in vermis
V-10* 54* 0 0 30 **
Family 2
III-3 53 35 11.00 14.00 30 Cerebellar atrophy, some scattered unspecific white matter lesions
*This subject was without symptoms and signs, but was confirmed to have the SCA14 mutation.
**MRI not performed.
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one subject who had suffered a stroke and could there-
fore not participate. One subject (Subject V10) was
confirmed to have the mutation, but had no motor symp-
toms or signs at examination. This subject was included
in the study as affected, but excluded from the neuro-
psychological group analyses.Controls
Ten family members, six females and four males, were
included as intrafamilial controls. None of them carried
the SCA14 mutation. No other neurological disease was
known in these controls. They consisted of six 1st degree
relatives, two 2nd degree relatives, and two spouses, and
were matched for age and education (Figure 1, Table 3).
The age ranged from 18 to 68 years. No intrafamilialFigure 1 Pedigree of SCA14 Family 1 at time of testing. All affected liv
controls included in the study are marked with C. The pedigree is slightly mcontrols were available for testing for the single affected
subject in Family 2.
Clinical assessment
All affected subjects underwent a standardized neuro-
logical clinical investigation at baseline and at three years
follow up. They were evaluated according to a standard
clinical protocol for ataxia patients, the Scale for Assess-
ment and Rating of Ataxias (SARA) [29]. The SARA scale
has a total score from 0 (no ataxia) to 40 (most severe
ataxia). A seven-stage functional scale was used to meas-
ure motor disability; 0, normal; 1, mild ataxia signs at
examination, but no functional handicap; 2, mild func-
tional disability, able to walk and run; 3, walking without
help, unable to run; 4, unilateral help to walk; 5, bilateral
help to walk; 6, wheelchair-bound; 7, bedridden. At three
years follow up, standard brain MRI without contrasting subjects were included in the study. Intrafamilial unaffected
odified due to anonymization purposes.
Table 3 Clinical and affective characteristics of SCA14 affected subjects and intrafamilial controls
Affected n = 9 Intrafamilial controls n = 10
Median/Mean (SD) Median/Mean (SD)
SARA 1, at baseline 5.50/5.83 (3.31) 0
SARA 2, at three years follow up 8.50/8.28 (3.62) 0
Disease duration (in years) 10.00/13.00 (8.60) 0
Age at examination (in years) 44.00/37.33 (14.17) 43.5/41.9 (13.9)
Disability stage 1, at baseline 2.00/2.00 (0.50) 0
Disability stage 2, at three years follow up 2.00/2.00 (0.50) 0
Mini-Mental State (MMS) 30.00/29.67 (0.50) 0
Education (in years) 10/10.33 (2.2) 10/10.8 (2.1)
Male: Female 7:2 4:6
Mean (n = 9) Mean (n = 9)*
SCL-90
Total 0.33 (0.41) 0.38 (0.21)
Somatization 0.71 (0.80) 0,67 (0.50)
Obsessive-compulsive 0,46 (0.69) 0,70 (0.59)
Interpersonal sensitivity 0.42 (0.43) 0.15 (0.16)
Depression 0.32 (0.48) 0.48 (0.50)
Anxiety 0.20 (0.28) 0.29 (0.25)
Hostility 0.28 (0.49) 0.11 (0.12)
Phobic anxiety 0.25 (0.43) 0.10 (0.14)
Paranoid ideation 0.22 (0.30) 0.17 (0.19)
Psychoticism 0.09 (0.14) 0.03 (0.05)
Extra-scale 0.50 (0.69) 0.83 (0.51)
*n = 9, one control was known to have ADHD and had a total SCL-90 score of 1.94, and was excluded from the analyses as an outlier.
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[30] and anxiety score the Symptom Checklist-90 Re-
vised (SCL-90-R) [31] were performed in all symptomatic
subjects. A neuropsychological test panel as detailed in
Table 4 was performed in all included subjects.
All included unaffected family members were investi-
gated clinically and screened for neurological symptoms
and signs, and they were tested with the same neuro-
psychological tests in the same order as the affected
subjects.
Genetic testing
DNA was extracted from peripheral blood lymphocytes
using standard techniques, and the subjects were identi-
fied by direct sequencing of exon 5 in the PRKCG-gene
[19]. All healthy related intrafamilial controls were tested
for the same mutation.
Neuropsychological methods
The test panel was specifically selected to minimize
motor skills’ interference and a special emphasis was put
on covering executive, visuospatial and verbal domains
in accordance to the CCAS. General cognitive level,psychomotor speed and memory function were also
covered (Table 4). The testing lasted for two hours and
was performed within standardized conditions in neuro-
logical out-patient-clinics, preferably at the subjects’ local
hospital to avoid exhausting travel ahead of testing. The
testing was conducted by the same neurologist (I.W.)
under supervision of an experienced neuropsychologist
(N.I.L). The subjects were allowed to take breaks when
they wanted. The tests were scored according to standard
procedures as described in the test manuals.
General cognitive functioning
General cognitive functioning was estimated by using the
2-subtest Norwegian version of Wechslers Abbreviated
Scale of Intelligence (WASI) [32], consisting of Vocabu-
lary and Matrix Reasoning which gives an estimate of
verbal and performance IQ, respectively.
Memory functions
Verbal learning and memory was evaluated with California
Verbal Learning Test (CVLT) [33]. A 16-word list is
presented in a five-trial manner with free and delayed
recall and recognition. Non-verbal learning and memory
Table 4 Comparison of cognitive performance between SCA14 affected subjects and intrafamilial controls
Norm data Affectedn = 9 Intrafamilial controlsn = 10 Affected
vs norm
Controls
vs norm
Affected
vs controls
Subject,
V-10**
SubjectIII 3***
One-sample
t-test
One-sample
t-test
MannWhitney
U test
Mean Median ± interquartile
range
Median ± interquartile
range
p-value* p-value* p-value* Scores Scores
General cognitive functioning
Intelligence Quotient (IQ) 100 92.0 ± 10 100.5 ± 18 0.020 0.563 0.288 91 92
Vocabulary (t-score) 50 41.0 ± 8 44.0 ± 14 0.001 0.194 0.120 43 39
Matrix Reasoning (t-score) 50 53.0 ± 11 51.5 ± 18 0.479 0.602 1.000 47 52
Verbal executive function
Controlled Word Fluency Test, Phonologic (FAS) t-score 50 45.0 ± 6 46.5 ± 9 0.003 0.174 0.410 43 40
Controlled Word Fluency Test, Semantic t-score 50 53.0 ± 9 53.0 ± 9 0.506 0.200 0.711 47 55
Learning and memory
CVLT Learning percentil 50 59.0 ± 11 48.0 ± 9 0.866 0.866 0.041 52 65
CVLT Long-Delay Free Recall 10 14.0 ± 2 12.0 ± 2 <0.001 0.005 0.065 9 12
CVMT Learning percentil 50 10.3 ± 42.2 11.5 ± 19.3 0.022 <0.001 0.806 8.6 10.3
CVMT Memory percentil 50 27.6 ± 59.6 15.1 ± 10.8 0.278 <0.001 0.135 13.8 27.6
Visuoperceptive skills
Line Orientation Test 25.4 27.0 ± 11 28.0 ± 3 0.359 0.288 0.136 19 17
Working memory
Digit Span, sub-test, WAIS-R 10 10.0 ± 5 10.0 ± 3 0.540 0.310 0.868 8 10
Paced Auditory Serial Addition Test PASAT 46 39.0 ± 22 38.5 ± 10 0.049 0.036 0.653 **** 32
Psychomotor speed
Stroop Color Naming Test 1 10 7.0 ± 3 9.5 ± 5 <0.001 0.111 0.284 7 6
Stroop Color Naming Test 2 10 7.0 ± 2 7.0 ± 5 0.003 0.026 0.706 3 7
Executive functions, inhibition and set-shifting
Stroop Color Naming Test 3 10 9.0 ± 4 9.0 ± 3 0.373 0.327 0.868 3 12
Stroop Color Naming Test 4 10 9.0 ± 4 10.5 ± 3 0.111 0.842 0.137 6 9
WCST total errors t-score 50 53.0 ± 20 38.5 ± 10 0.928 0.005 0.141 46 56
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Table 4 Comparison of cognitive performance between SCA14 affected subjects and intrafamilial controls (Continued)
WCST categories 5.1 6.0 ± 1 5.5 ± 2 ***** ***** 0.257 5 6
WCST conceptual level responses t-score 50 52.0 ± 20 39.0 ± 6 0.977 0.001 0.093 47 58
WCST perseverative responses t-score 50 55.0 ± 26 37.0 ± 12 0.661 0.002 0.064 49 55
*p-values < 0.05 are highlighted in bold.
**Subject V-10’s individual scores. V-10 is confirmed to carry SCA14 mutation, but was motor asymptomatic and not included in group analyses.
***Subject III-3’s individual scores. III-3 is the only subject from Family 2, and is also included in affected group analyses.
****Subject V-10 did not fulfill PASAT test.
*****not available for t-test due to not normal distribution.
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Figure 2 MRI from four SCA14 subjects at time of neuropsychological testing. A: Subject VI-2, disease duration 7 years; B: Subject VI-3, disease
duration 10 years; C: Subject III-3, disease duration 18 years; D: Subject V-3, disease duration 25 years.
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(CVMT) [34].Visuoperceptive skills
The Line Orientation Test [35] measures the ability to
judge the orientation and angles of lines in space, and
requires no manual response.Working memory
We used the forward and backward Digit-Span subtest
from WAIS-R [36] in which the participants are presented
with a series of digits and must immediately repeat them
back, first in forward and then in backward direction. In
addition we used the Paced Auditory Serial Addition Test
(PASAT) [37,38] in which the participants hear numbers
with two seconds interval and are asked to add the num-
ber they just heard with the number they heard before, re-
quiring working memory and attention.Psychomotor speed
The first two paradigms of the Stroop Color Naming
Test [39] were used to give an estimate of psychomotor
speed and consist of reading color names and naming
color patches as rapidly as possible.Executive function
Executive functions with selective attention and inhib-
ition were tested with the Stroop Color Naming Test
paradigm 3 (inhibitory) and 4 (set shifting), where the
participants were asked to name the ink color of written
incongruous color words as rapidly as possible, thereby
assessing cognitive flexibility, selective attention and inhibi-
tory control. To study higher executive and set-shifting
functions the Wisconsin Card Sorting Test (WCST-128)
[40] was used. The participants were asked to match
128 cards according to color, quantity, and design with-
out being told the pattern on beforehand, measuring the
ability to form abstract concepts and cognitive flexibility.Verbal executive functions
We used The Word Fluency Test [37] which consists in
rapidly saying words that starts with a specific letter F-A-S
(phonologic FAS subtest) and animals and kitchen acces-
sories (semantic subtest). The first subtest is more execu-
tively demanding and was used to evaluate verbal executive
functions.Depression, anxiety and somatization
Depression, anxiety and somatization were assessed by
a self-report inventory, SCL-90-R [31] (Table 3).
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All tests have internationally standardised published norms.
For comparison with normal data, we used the most accur-
ately matched available norm data for each test, adjusted
to age-, education and/or sex, according to what was
validated and available for the individual test.
Data analysis
All statistical analyses were performed using SPSS for
Windows version 19.0 (SPSS Inc).
Due to the small group sample, non-parametric statis-
tical methods with Mann–Whitney U test using median
as middle value were chosen when comparing the two
tested groups, and the significance level was set to 0.05.
After controlling for normality with Shapiro Wilk test of
normality, the affected subjects’ performance using mean
as middle value was compared to norm material with
one-sample t-test, and the mean t-score from the norm
material was used as test value. Clinical neurological
progression in the three year study interval was assessed
by Related Samples Wilcoxon Signed Rank Test.
Correlations between disease duration, motor symp-
toms, age of onset and general cognitive functioning
were assessed by the non-parametric Spearman’s correl-
ation coefficient due to the small sample size. Correction
for multiple comparisons was done using the Bonferroni
correction.
Ethics
Written informed consent was obtained from all in-
cluded family members (Ethical agreement n˚129/04011,
Regional Ethic Committee in Norway).
Results
All tests were conducted on all subjects except in the one
asymptomatic affected subject who declined to perform
the PASAT and SCL-90 tests.
Clinical data
The duration of symptoms among the affected subjects
ranged from 0 to 27 years, and there was no significant
age difference between the two tested groups. (Table 2
and Table 3) SARA score in the affected subjects was
significantly lower at baseline compared to the score at
three-year follow-up (p = 0.007). Overall disability was
mild with Disability Score ranging from 1 to 3, and did
not vary during the study observation time. All had slowly
progressive cerebellar ataxia except one who had neither
symptoms nor findings at either of the two clinical exami-
nations, and was therefore excluded from the neuro-
psychological group analyses. In addition, 8 subjects had
pyramidal signs, consisting of extensor plantar response (6
subjects), hyperreflexia in the lower limbs (4 subjects) andincreased tone in the lower limbs (5 subjects). One sub-
ject had myoclonus and one subject had head tremor.
MRI was performed in eight subjects and showed iso-
lated cerebellar atrophy in all, except in one subject where
also unspecific white matter hyperintensities were de-
scribed. In five of the eight subjects, atrophy was clearly
most prominent in the vermis (Figure 2).
The results of the psychopathological self-report scheme
SCL-90-R showed no significant differences between af-
fected and unaffected family members, neither in total
nor in any of the subcategories.
Genetic results
The same single C to A nucleotide substitution at pos-
ition 417 of exon 5 was found in the PRKCG gene in all
affected subjects, leading to a missense mutation at the
protein level, p.H139Q.
Neuropsychological results
The affected subjects showed no significant impairment
compared to intrafamilial controls in any of the tested
neuropsychological domains (Table 4) but lower verbal
executive function was observed. The affected performed
significantly better than the intrafamilial controls in verbal
memory. In the WCST the affected subjects also showed
better results than the intrafamilial controls, with less
perseveration and a better ability to keep their answers
on a conceptual level, although it did not reach statis-
tical significance.
Compared to population based norm data, the affected
subjects showed significantly lower total IQ, verbal IQ,
psychomotor speed, verbal executive function, working
memory, attention and visual learning. Verbal learning
was better in the affected subjects than expected from
norm. However, compared to norm, lower attention, visual
learning and memory, working memory and psychomotor
speed were also present in the intrafamilial controls.
Intellectual functioning
Total and verbal IQ, but not executive IQ, were lower in
affected subjects compared to the intrafamilial controls.
The low estimate of verbal IQ with a mean t-score of
39.9 differed considerably from norm data and contrib-
uted to the low mean total IQ score in the affected group
(x = 93.0). The total IQ in the affected group was signifi-
cantly lower than expected from norm, even though only
one affected subject scored below 1 SD from norm (x = 83).
In verbal IQ four affected subjects scored within the
clinically impaired range below 1 SD from norm (× = 40),
while none of the nine affected scored above the mean
expected from norm. In executive IQ seven of the nine
affected scored above the mean norm expectance of 50,
while only one was in the clinically impaired range. None
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IQ, in contrast to four of the intrafamilial controls.
Memory functions
The affected subjects showed a significantly better verbal
learning than the intrafamilial controls. Also compared
to norm, verbal memory was significantly better among the
affected subjects than expected. Six of the affected subjects
showed a score 1 or more SD above what is expected in the
long delay CVLT, as in contrast to only three of the intrafa-
milial controls.
In the CVMT both the mean t-score of visual learning
(× = 14.96) and visual memory (× = 11.52) in the intrafa-
milial control group were lower than the affected subjects’
visual mean learning (× = 21.34) and memory (× = 33.82)
t-score. In these tests the SDs were very large (visual
learning SD = 29.0, visual memory SD = 35.9 in affected
subjects, and visual learning SD = 16.3, visual memory
SD = 6.1 in intrafamilial controls), and the difference be-
tween the groups did not reach statistical significance.
However, both groups showed significant impairment
compared to norm.
Regarding working memory, no significant difference
was seen between the two tested groups in the PASAT-
test. Both groups scored significantly below the age and
IQ-matched expected mean norm score of 46, with a
mean score of 36.44 for the affected, and 39.4 for the
intrafamilial controls. None of the groups showed the same
working memory deficit in the Digit Span Test, where there
was no difference either between the tested groups or
to norm.
Visuoperceptive skills
No difference was found between the tested groups in the
Line Orientation Test. The range within the affected sub-
jects’ group was wide with raw score performances from
17/30-30/30, and when scores were corrected for age and
gender [35,41], two subjects scored within the “moderate
defective” category on the 4th percentile in the norm ma-
terial, but on a group level there was no difference to norm.
Psychomotor speed
The affected subjects performed similarly to controls in
Stroop 1 + 2. Compared to norm, the affected subjects
had a significantly lower mean Scaled Score in the read-
ing (× = 6.7) and color naming (× = 7.4) subtests (Stroop
1 + 2), and the unaffected control group also scored sig-
nificantly below norm in Stroop 2 (× = 7.8). In Stroop 1
only one affected subject scored similarly or above the
expected Scaled Score of 10 (× = 11), while five un-
affected family members did so. All affected subjects
and seven of the unaffected controls scored below the
Scaled Score of 10 in Stroop 2, where one affected subject
also scored more than two SDs below norm (× = 3).Executive functions
Verbal fluency in the affected showed no difference to
unaffected family members. However, towards norm the
affected scored significantly lower in the most verbal
executively demanding FAS-test. All affected, and nine
of the ten unaffected controls had a lower performance
on the FAS-test as compared to the Semantic subtest.
Regarding non-verbal executive functions, the affected
subjects performed below intrafamilial controls in Stroop
4. The single lowest performance was in the unaffected
control group with a Scaled Score of 2, but seven un-
affected family members scored above the expected Scaled
Score of 10, while only four of the affected subjects did so.
The affected tended to perform better than the unaffected
controls on a trend level in two subtests of the WCST. In
the total errors subtest seven of the ten affected had a
t-test score above 50, in contrast to only two of the
unaffected controls. There were large range and confi-
dence intervals among the affected subjects, and both
the highest (t-score 61) and lowest (t-score 33) per-
formance of WCST total errors subtest was observed
in the affected group. On a group level there was no
evidence of impairment of higher executive functions
among the SCA14 subjects, either towards intrafamilial
controls or norm, when assessed by WCST and Stroop 3 +
4 subtests.
Correlations between motor symptoms, duration, age of
onset and cognition
The significance level was corrected for multiple testing
with Bonferroni, which gave a cut-off for statistical sig-
nificance of p = 0.00068, and no correlations were found
to be statistically significant. The SARA-value at the time
of neuropsychological testing (SARA2) showed a positive
correlation to higher total score on the psychopathological
scale SCL-90-R (r = .69, p = 0.041). A positive correlation
was also observed between disease duration and Disability
score (r = .64, p = 0.048). The subject with the longest dur-
ation (27 years) also had the highest total IQ performance
(IQ = 107), and duration of disease showed a correlation
to higher IQ on a trend level (r = .61, p = 0.081). There
was a negative correlation between age at onset and
performance in the WCST, with regard to conceptual
level responses (r = −.587, p = 0.096) and perseverative
responses (r = −.637, p = 0.065). The three affected sub-
jects with the lowest disease duration (1, 7 and 8 years)
were the same subjects who had the lowest WCST per-
severation t-scores among the affected (t-score 36, 37
and 33).
The one somatically asymptomatic affected subject was
excluded from the neuropsychological group analyses to
avoid bias. Inclusion of this subject in the group assess-
ment did not alter the overall differences between the
affected subjects, either to unaffected family members
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sented in Table 4.
In the two SCA14 families tested, only one individual
was available for testing in Family 2. His scores were in
the similar range as the other affected subjects’ scores
(Table 4).
Discussion
These SCA14 subjects showed no statistically significant
cognitive impairment to intrafamilial unaffected controls.
We report verbal executive deficits in the affected sub-
jects, but contrary to our hypothesis and to previous
reports, non-verbal executive functions were not impaired;
the affected subjects showed less perseveration than un-
affected family members and significantly better verbal
learning.
Bias
Both affected subjects and unaffected intrafamilial con-
trols scored below norm in several neuropsychological
domains. Among the unaffected six 1st degree and two
2nd degree relatives in the control group inherited cog-
nitive characteristics independent of ataxia may be present.
The use of intrafamilial controls will reduce environmental
and genetic bias. We had to include two spouses as there
were no other available unaffected relatives fulfilling the
age and education matching criteria. This is unfortu-
nately the drawback of dealing with rare diseases and
small families. This choice still reduces the environmen-
tal bias. However, the use of intrafamilial controls may
also lead to a selection bias, as it is reasonable to assume
that people choose their mates and social surroundings
according to their own intellectual level and profile. In
addition, the unaffected family members may be influ-
enced by the affected, inducing a certain amount of
phenocopy effect. The use of norm in addition to intra-
familial controls should reduce these confounding fac-
tors. We used international norm data, which may not
fully represent the Norwegian population, especially as
the Norwegian education system since 1994 has included
12 years of compulsory school education, even for artisan
and craftsman qualifications. This influences the length of
education for the youngest subjects in our cohort, and
may give a bias towards higher scores in the norm popula-
tion than in the Norwegian background population, and
subseqeuently appear as an exaggeration of the impair-
ment in the tested subjects. Thus we focus primarily on
the domains where affected subjects differ from intrafami-
lial unaffected controls.
No single neuropsychological domain was significantly
reduced compared to both norm and intrafamilial con-
trols. This may partly be due to the choice of statistical
methods. Due to the small sample size, non-parametric
statistical methods were used when comparing the testedgroups, as in contrast to parametric methods when com-
paring to norm data. We may thus have lost some statis-
tical power, which may lead to a type II error where we
falsely can have rejected a true cognitive impairment.
This is however one of the main drawbacks of studies
in rare disorders; our sample was small but could not
be enlarged, as all identified testable and symptomatic
SCA14 adult individuals in Norway were included.
In order to avoid motor bias in these ataxic patients,
the test panel was selected to require minimal manual
response, and the tests apparently worked well in the
subjects. However, dysarthria may also affect the results.
The reported psychomotor speed impairment could be
due to dysarthria, but as the results only showed a subtle
and not significant difference from unaffected family
members in Stroop 1 + 2, we believe dysarthria is of
minor importance to our results.
Affected subjects vs. population based norm data
Compared to population-based norm data, specific as-
pects of cognitive function were significantly impaired in
SCA14, partly consistent with the Cerebellar Cognitive
Affective Syndrome (CCAS) where deficits in executive
function, spatial cognition, language and affect are de-
scribed. Even though the range of performance was very
large, the affected showed set-shifting, planning and ab-
stract reasoning within normal norm range, indicative of
preserved non-verbal executive functions. Towards norm
the affected subjects showed significantly reduced total IQ
due to reduced verbal IQ, and impaired verbal executive
function, attention, working memory, psychomotor speed
and visual learning. Verbal memory, on the other hand,
was better in the affected than expected from norm data.
However, except from in IQ and verbal executive function,
the unaffected family members showed the same trends
as the affected towards norm. The differences can there-
fore hardly be due to SCA14 alone.
Previous studies
SCA14 has been associated with cognitive impairment in
previous studies (Table 1). Comparison with our results is
difficult as different neuropsychological tests were used
[17,25-27], and these studies have not included control
groups. Earlier descriptions include primarily dysexecutive
abnormalities, but also memory loss, attention deficit,
frontal behaviour abnormalities, difficulty in understand-
ing and dementia. We introduced intrafamilial controls in
addition to norm, and assessed a homogeneous test panel
testing broadly on different neuropsychological domains
with an emphasis on domains hypothesized to be im-
paired in cerebellar patients. Our results do not support
previous findings of severe cognitive impairment spe-
cific of SCA14. In particular, we could not confirm the
earlier reported marked reduction of executive IQ and
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pronounced verbal impairment. The differences we find
compared to previous studies could partly result from
genotype specificities, as the mutations reported by other
groups were different from the p.H139Q mutation present
in our study. Cognitive impairment in SCA14 may thus be
associated with specific mutations, rather than being part
of a common phenotype. As few families with SCA14 have
so far been reported, genotype/phenotype correlations
are, however, not yet investigated.
Intellectual functioning
One affected subject had a clinically relevant total IQ
reduction, but four had a clinically impaired verbal IQ.
This indicates normal non-verbal abstract problem solving
and spatial reasoning, while the ability to use language to
solve problems was reduced. Only lower verbal IQ con-
tributed to the affected group’s reduced total IQ, as com-
pared to unaffected family members. This is in contrast
to the four full-scale IQ assessments that are previously
reported in SCA14 [17,25] where reduced executive IQ
caused the total IQ impairment. Verbal IQ assessment
is criticized for being more social and education biased
than executive IQ. All the tested subjects lived in an in-
dustrial area of Norway, and only one subject in both
groups had an academic education. Thus, the divergence
between verbal and non-verbal abilities may be due to en-
vironmental factors in our cohort. The one affected sub-
ject with an academic background indeed had the best
verbal IQ in her group (t-score = 47), but the same subject
also had a comparatively higher executive IQ (t-score = 54),
underscoring a lower verbal than executive IQ in these
SCA14 patients, possibly due to the disease.
Memory functions
Although visual learning and memory were similar in the
tested groups, the performance range interval was remark-
ably large in the affected and conclusions are thus hard
to draw from this small cohort. Unexpectedly, verbal
learning was significantly better in the affected. Although
somewhat speculative at this stage, one hypothesis could
be that increased verbal memory might serve as a com-
pensatory mechanism, mediated by impaired verbal func-
tions in SCA14 subjects. This possibility needs to be
specifically investigated in future studies.
In accordance to previous studies, we found working
memory deficits towards norm in the PASAT test. How-
ever, the unaffected family members performed even lower
towards norm, and we cannot interpret this as a specific
SCA14 finding.
Executive function
Contrary to our hypothesis, the only consistent evidence
of dysexecutive impairment in our study was detected inverbal functions. The discrepancy in the affected subjects’
performance in the two subtests of word fluency, suggests
reduced verbal executive function. This divergence cannot
simply be explained by dysarthria, as impairment in both
tests would be expected if dysarthria was a major com-
ponent. This finding is in accordance with observations
from other cerebellar disorders, where verbal fluency is
one of the most consistently reported impairments [42,43].
However, non-verbal executive functions were unex-
pectedly weaker in the unaffected family members. Indeed
the affected tended to perform below their unaffected
controls in Stroop 4, but the affected subjects showed
surprisingly better performances than unaffected con-
trols with less perseveration and higher ability to find
the correct sorting principles as assessed with WCST.
Further studies are needed to verify these findings. It is
interesting to note that also earlier studies have failed to
find consistent performance differences between cerebel-
lar patients and controls in variants of WCST [1,42,44],
even though cerebellar activation has been observed dur-
ing the performance of WCST in healthy subjects [45,46].
Executive dysfunction is the deficit most consistently
reported previously in SCA14 patients, and may partly
result from the selection of tests in these studies, with
Ravens Progressive Matrix 47 [47] most widely adminis-
tered [17]. This test resembles the Matrix Reasoning used
in our study, but performance of Ravens Progressive
Matrices is known to be adversely correlated to age and
female sex [48]. The discrepancy may thus be partly due
to the predominance of young male subjects in our co-
hort as compared to previous reports where older and
more female subjects were included.Correlations
We hypothesized an aggravation of cognitive impairment
parallel with duration of disease and increased motor dis-
ability. Unexpectedly, duration of disease showed correl-
ation to higher IQ. Even though this correlation was not
statistically significant, it is tempting to hypothesize that
compensatory plasticity in the brain may develop over
time in the case of early cerebellar dysfunction. An in-
verse correlation between age of onset and performance
was also seen in WCST, where the two affected subjects
with the lowest performance in the WCST had the latest
age of onset. As this is a cross-sectional neuropsycho-
logical study, we have no data on the development of
cognitive symptoms with duration in the individual
affected subjects. The cohort is too small to draw conclu-
sions, but we found no support for our primary hypothesis
of progression of cognitive symptoms with duration.
Nevertheless, plasticity would be in accordance to earl-
ier observations of chronic cerebellar lesions leading to
milder cognitive implications than acute injury [1], and
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ing to be transient.
Affective impairment is suggested by the positive cor-
relation between motor symptoms severity and psycho-
pathological symptoms assessed by SCL-90-R. However,
the SCL-90-R also includes a scale of somatic symptoms
such as fatigue and muscle pain, and by excluding the
somatization scale from the analysis, the correlation weakens
and one might interpret this covariance as caused by the
somatic symptoms of SCA14. There remains, however, a
weak correlation between motor symptoms and phobic
anxiety subcategory, which could be consistent with CCAS’
prediction of dysregulated and inappropriate affect. These
results will also need confirmation in larger studies, as
they can be of special importance for the follow up of
SCA14 patients.
All our affected subjects shared the same p.H139Q mu-
tation in the PRKCG gene. Despite different genetic and
environmental background, the only subject in Family 2
showed the same cognitive phenotype with the rest of
the affected, with reduced verbal functions and intact
non-verbal executive functions (Table 4). Interestingly,
the same pattern was also observed in the motor asymp-
tomatic subject in Family 1, and this subject performed
in the lower range of the affected group (Table 4).
Although the PRKCG gene is expressed most abun-
dantly in the Purkinje cells, it is expressed in the whole
brain. Clinically we did observe slight pyramidal signs in
some of the affected, and we cannot therefore rule out
degeneration of extracerebellar neurological structures.
Radiological and pathological studies in SCA14 patients
are scarce, but a MRI case series showed cerebellar atro-
phy, and notably no cortical atrophy or white matter
abnormalities [22,23]. In our study MRI was done in
eight of the subjects, and isolated cerebellar atrophy
was the most consistent finding (Figure 2, Table 2). This
does support a primarily cerebellar explanation of the
cognitive profile of this cohort.Conclusion
Only subtle cognitive impairment was found in SCA14
subjects compared to unaffected intrafamilial matched
controls. Executive functions were not impaired to the
extent that is described in the CCAS or previously re-
ported in SCA14 patients, and impairment was restricted
to verbal dysexecutive abnormalities.
Better verbal learning than intrafamilial controls may
indicate possible compensatory mechanisms in affected
subjects. This could point towards an interesting potential
for cognitive rehabilitation for SCA14 patients. Genotype-
phenotype correlations remain to be studied for cognition
in SCA14. Longitudinal studies are warranted in order to
confirm and strengthen the presented findings.Abbreviations
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